
Digitizing Compassionate Access Programs with Zelthy
Zelthy’s digital platform cut compassionate access approval times by 65%, lowered costs 40%, and made therapy access seamless and compliant in Australia.
A global pharma company used Zelthy’s digital health platform to raise disease awareness and connect patients with treatment.
Key Outcomes:
500,000+ website visits in 9 months
80,000+ consultation requests
30% conversion from visitor to appointment
2x increase in therapy initiations in target cities
Stronger HCP equity via warm leads and educational support

In today’s digital-first world, patients often begin their healthcare journey online—searching for symptoms, reading about conditions, and looking for credible treatment options. For pharma companies, this shift presents both a challenge and an opportunity: how to educate patients effectively, guide them toward trusted resources, and ultimately connect them to the right healthcare professionals (HCPs).
A global pharmaceutical leader in a niche therapy area faced exactly this challenge. While the company had launched a breakthrough treatment, awareness among patients remained low, and there was no centralized platform for education and engagement. To bridge this critical gap, the company partnered with Zelthy to build a disease awareness and patient engagement platform that combined education, action, and measurable outcomes.
While the pharma company had launched an innovative treatment in a niche therapy area, it faced several challenges in reaching and educating potential patients:
To succeed, the company needed a digital-first solution that could connect awareness with action—informing patients, encouraging consultations, and strengthening relationships with HCPs.
Using Zelthy, the pharma company launched a comprehensive digital therapy awareness platform, accessible via web and mobile.
Key features included:
The initiative drove value across the board—improving patient access while building long-term HCP loyalty:
The company selected Zelthy for its:
By partnering with Zelthy, the pharma company was able to transform its patient engagement strategy from fragmented campaigns into a holistic digital health initiative. Patients gained access to trusted resources and timely care, HCPs benefited from qualified referrals, and the company achieved measurable growth in therapy initiations.
This case study highlights how pharma leaders can leverage Zelthy’s scalable, compliant platform to move beyond awareness, creating patient-centric ecosystems that drive real healthcare outcomes.
Explore more case studies to see how we've helped other organizations achieve their goals.

Zelthy’s digital platform cut compassionate access approval times by 65%, lowered costs 40%, and made therapy access seamless and compliant in Australia.

Nivrit unifies patient data, cuts development time by 60%, and lowers cost by 80% for holistic, scalable women’s healthcare.

A digital vaccine ordering portal onboarded 3,000+ clinics, processed 12,000+ orders in 6 months, cut order-to-delivery time by 15%, and boosted repeat orders by 25%.